Clinical Trial | Sean Parker Institute for the Voice

Injection Augmentation Offers No Advantage Over Botulinum Toxin Chemodenervation to Patients with Essential Voice Tremor

March 19, 2018

An Institute study published in The Laryngoscope showed no clear benefit from injection augmentation over traditional botulinum toxin treatment in a small group of patients essential voice tremor. Botulinum toxin chemodenervation is often less than satisfactory in the...

Clinical Trial for Evaluation of Laryngeal Neuropathy using Transcranial Magnetic Stimulation is Now Open.

October 14, 2016

A clinical trial to evaluate laryngeal neuropathy using magnetic stimulation is now open for adult patients who have been diagnosed with vocal fold(cord) paresis or paralysis. Healthy volunteers are also sought to establish the parameters of the normal examination

Clinical Trial Details:...

Clinical Trial For Treatment Of Essential Voice Tremor Now Open

March 10, 2016

A trial at the Parker Institute, comparing injection augmentation to botulinum toxin treatment for essential voice tremor, is now recruiting patients. Patients with essential voice tremor are encouraged to review the trial information, and contact us if they seek further information.